Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial

The Lancet

Volumn 374, Issue 9690, 2009, Pages 628-634

  Kessler, David ^a   Lewis, Glyn ^b   Kaur, Surinder ^a   Wiles, Nicola ^b   King, Michael ^c   Weich, Scott ^d   Sharp, Debbie J ^a   Araya, Ricardo ^b   Hollinghurst, Sandra ^a   Peters, Tim J ^a  

^a University of Manchester   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Department of Mental Health Sciences ^*  (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONLINE SYSTEM; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPIST; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 68849130879     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61257-5     Document Type: Article

References (26)

1. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
2. Hollinghurst S., Kessler D., Peters T.J., and Gunnell D. Opportunity cost of antidepressant prescribing in England: analysis of routine data. BMJ 330 (2005) 999-1000
3. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., and Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5 (2008) e45
4. Medicines and Healthcare products Regulatory Agency. Selective serotonin reuptake inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data. http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494 (accessed July 22, 2009).
5. Department of Health. Improving Access to Psychological Therapies (IAPT) Commissioning Toolkit. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_084065 (accessed July 22, 2009).
6. Churchill R., Hunot V., Corney R., et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess 5 (2001) 1-173
7. Christensen H., Griffiths K.M., and Jorm A.F. Delivering interventions for depression by using the internet: randomised controlled trial. BMJ 328 (2004) 265
8. Proudfoot J., Ryden C., Everitt B., et al. Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 185 (2004) 46-54
9. Simon G., Ludman E., Tutty S., Operskalski B., and Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA 292 (2004) 935-942
10. Christensen H., Griffiths M., Mackinnon J., and Brittliffe K. Online randomized controlled trial of brief and full cognitive behaviour therapy for depression. Psychol Med 36 (2006) 1737-1746
11. Pennebaker J.W., and Seagal J.D. Forming a story: the health benefits of narrative. J Clin Psychol 55 (1999) 1243-1254
12. Beattie A., Shaw A., Kaur S., and Kessler D. Primary care patients' expectations and experiences of online Cognitive Behavioural Therapy (CBT) for depression: a qualitative study. Health Expect 12 (2009) 45-59
13. Beck A., Steer R., and Brown G. Manual for the Beck depression inventory (1987), The Psychological Corporation, San Antonio
14. WHO. International Statistical Classification of Diseases and Related Health Problems 10th revision (2007), World Health Organization, Geneva. http://www.who.int/classifications/apps/icd/icd10online (accessed July 22, 2009).
15. Lewis G., Pelosi A.J., Araya R., and Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med 22 (1992) 465-486
16. Blackburn I., James I., Milne D., et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother 29 (2001) 431-446
17. Taylor E., and Klein D. Assessing recovery in depression: validity of symptom inventories. Cogn Ther Res 13 (1989) 1-8
18. Jenkinson C., and Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy 2 (1997) 14-18
19. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
20. Dunn G., Maracy M., and Tomenson B. Estimating treatment effects from randomized clinical trials with non-compliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 14 (2005) 369-395
21. Little R.J., and Rubin D.B. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Ann Rev Public Health 20 (2000) 121-145
22. Roberts C., and Roberts S.A. Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials 2 (2005) 152-162
23. van Schaik D.J., van Marwijk H.W., and van der Windt D.A. Effectiveness of psychotherapy for depressive disorder in primary care: a systematic review. Tijdschr Psychiatr 44 (2002) 609-619
24. Ward E., King M., Lloyd M., et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. BMJ 321 (2000) 1383-1388
25. Teasdale J., Moore G., Hayhurst H., Pope M., Williams S., and Segal Z. Metacognitive awareness and prevention of relapse in depression. J Consult Clin Psychol 70 (2002) 275-287
26. Derubeis R.J., Hollon S.D., Amsterdam J.D., et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 62 (2009) 409-416